JO3172B1 - تركيبة وطريقة وتحضير الصفراء الصناعية - Google Patents

تركيبة وطريقة وتحضير الصفراء الصناعية

Info

Publication number
JO3172B1
JO3172B1 JOP/2008/0286A JOP20080286A JO3172B1 JO 3172 B1 JO3172 B1 JO 3172B1 JO P20080286 A JOP20080286 A JO P20080286A JO 3172 B1 JO3172 B1 JO 3172B1
Authority
JO
Jordan
Prior art keywords
preparation
acid composition
bile acid
synthetic bile
free
Prior art date
Application number
JOP/2008/0286A
Other languages
English (en)
Inventor
Rathan Prasad Achampeta
Kumar Sahoo Akhila
Gregory Reid John
M Moriarty Robert
A Swaringen Roy Jr
E David Nathaniel
Ahmeduddin Mahmood Nadir
Original Assignee
Kythera Biopharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41226994&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JO3172(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US12/035,339 external-priority patent/US20080318870A1/en
Priority claimed from GB0807615A external-priority patent/GB2452358C/en
Application filed by Kythera Biopharmaceuticals Inc filed Critical Kythera Biopharmaceuticals Inc
Application granted granted Critical
Publication of JO3172B1 publication Critical patent/JO3172B1/ar

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/007—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Child & Adolescent Psychology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Peptides Or Proteins (AREA)

Abstract

يتعلق الاختراع الحالي بأحماض صفراوية وتركيبات وطرق لتخليقها واستخدامها. وعلى نحو أكثر تحديداً، يتعلق الاختراع بحمض ديوكسي كوليك والتركيبات ذات الصلة، حيث تكون التركيبات المذكورة خالية من جميع الشقوق ذات الأصل الحيواني وخالية من شقوق مولدة للسخونة.
JOP/2008/0286A 2007-06-19 2008-06-18 تركيبة وطريقة وتحضير الصفراء الصناعية JO3172B1 (ar)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US94503507P 2007-06-19 2007-06-19
US95687507P 2007-08-20 2007-08-20
US12/035,339 US20080318870A1 (en) 2007-06-19 2008-02-21 Synthetic bile acid compositions and methods
GB0807615A GB2452358C (en) 2008-04-25 2008-04-25 Preparation of bile acids.
US12/153,446 US7902387B2 (en) 2008-04-25 2008-05-16 Preparation of bile acids and intermediates thereof

Publications (1)

Publication Number Publication Date
JO3172B1 true JO3172B1 (ar) 2018-03-08

Family

ID=41226994

Family Applications (1)

Application Number Title Priority Date Filing Date
JOP/2008/0286A JO3172B1 (ar) 2007-06-19 2008-06-18 تركيبة وطريقة وتحضير الصفراء الصناعية

Country Status (28)

Country Link
EP (3) EP2407475B1 (ar)
JP (2) JP2010530876A (ar)
KR (7) KR101916024B1 (ar)
CN (4) CN101711254A (ar)
AR (1) AR067440A1 (ar)
AU (1) AU2008265721B2 (ar)
BR (1) BRPI0813140C1 (ar)
CA (2) CA2789109C (ar)
CR (2) CR20170070A (ar)
CY (1) CY1116700T1 (ar)
DK (1) DK2407475T3 (ar)
EA (1) EA020806B1 (ar)
ES (2) ES2826429T3 (ar)
HR (1) HRP20150879T1 (ar)
HU (1) HUE025909T2 (ar)
IL (1) IL202203B (ar)
JO (1) JO3172B1 (ar)
MX (2) MX360094B (ar)
MY (1) MY160040A (ar)
NZ (1) NZ581081A (ar)
PH (1) PH12013500364A1 (ar)
PL (1) PL2407475T3 (ar)
PT (1) PT2407475E (ar)
SI (1) SI2407475T1 (ar)
SM (1) SMP201000003B (ar)
TW (2) TWI503327B (ar)
WO (1) WO2008157635A2 (ar)
ZA (1) ZA200907928B (ar)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101916024B1 (ko) * 2007-06-19 2018-11-08 키쎄라 바이오파마슈티컬즈 인코포레이티드 합성 담즙산 조성물, 방법 및 제조물
US20080318870A1 (en) 2007-06-19 2008-12-25 Kythera Biopharmaceuticals, Inc. Synthetic bile acid compositions and methods
JOP20180077A1 (ar) 2007-06-19 2019-01-30 Kythera Biopharmaceuticals Inc تركيبات وطرق لحمض صفراوي تخليقي
US8242294B2 (en) 2007-06-19 2012-08-14 Kythera Biopharmaceuticals, Inc. Synthetic bile acid compositions and methods
GB2480632A (en) * 2010-05-25 2011-11-30 Kythera Biopharmaceuticals Inc Preparation of 12-keto and 12-alpha-hydroxy steroids
US9127036B2 (en) * 2010-08-12 2015-09-08 Kythera Biopharmaceuticals, Inc. Synthetic bile acid compositions and methods
TWI572616B (zh) * 2011-06-16 2017-03-01 凱瑟拉生物製藥有限公司 去氧膽酸之組成物及用途及其相關方法
US20130102580A1 (en) * 2011-09-22 2013-04-25 Kythera Biopharmaceuticals, Inc. Compositions and methods related to deoxycholic acid and its polymorphs
US10081592B2 (en) 2012-03-23 2018-09-25 The Board Of Trustees Of The University Of Illinois Complex and structurally diverse compounds
CN103059087B (zh) * 2012-12-30 2015-10-14 中山百灵生物技术有限公司 一种脱氧胆酸的合成方法
KR101447901B1 (ko) * 2013-04-16 2014-10-16 한양대학교 산학협력단 지방세포 표적 비바이러스성 유전자 전달체
US10414791B2 (en) 2015-07-30 2019-09-17 Intercept Pharmaceuticals, Inc Methods for preparation of bile acids and derivatives thereof
JP2018532806A (ja) * 2015-11-04 2018-11-08 キセラ バイオファーマシューティカルズ インコーポレイテッド デオキシコール酸およびその塩による蓄積脂肪の処置方法
JP7050008B2 (ja) * 2016-06-06 2022-04-07 クリスタル ファーマ，エセ．ア．ウ． デオキシコール酸の調製方法、およびデオキシコール酸の調製に有用な中間体
EP3645548B1 (en) * 2017-08-03 2023-11-29 Medytox Inc. Methods for preparing bile acids
KR20200087776A (ko) * 2017-10-24 2020-07-21 비오나이스, 에스.엘.유. 데옥시콜산의 제조 방법
RU2705314C1 (ru) * 2019-03-18 2019-11-06 Федеральное бюджетное учреждение науки "Государственный научный центр прикладной микробиологии и биотехнологии" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека (ФБУН ГНЦ ПМБ) Способ производства сухих очищенных солей желчных кислот для бактериологии
KR102456989B1 (ko) * 2020-06-12 2022-10-21 (주)케어젠 항비만 활성을 가지는 디옥시콜산-펩타이드 결합체 및 이의 용도
US20230331766A1 (en) * 2020-09-18 2023-10-19 Seoul National University R&Db Foundation Method for mass-producing sodium taurodeoxycholate
CN114428171A (zh) * 2020-10-29 2022-05-03 深圳迈瑞生物医疗电子股份有限公司 检测甘胆酸的试剂盒、方法及用途
US20240325433A1 (en) 2021-07-16 2024-10-03 Scai Therapeutics Co., Ltd. Molecular association of bile acid or bile salt and pharmaceutical composition comprising same for locally reducing fat
CN117940111A (zh) 2021-07-16 2024-04-26 思凯制药有限公司 胆汁酸或胆盐的分子缔合物以及用于去除局部脂肪的包含其的药物组合物
CN114478676B (zh) * 2022-02-18 2024-05-10 国药集团化学试剂有限公司 一种脱氧胆酸钠的制备方法
CN115974949B (zh) * 2022-10-26 2023-12-22 湖南科瑞生物制药股份有限公司 一种植物源脱氧胆酸中间体的制备方法
CN118344420A (zh) * 2023-01-16 2024-07-16 北京诺博特生物科技有限公司 一种脱氧胆酸的制备方法
TW202602458A (zh) 2024-02-16 2026-01-16 美商賽諾菲巴斯德公司 用於製備去氧膽酸之方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2321598A (en) * 1940-10-07 1943-06-15 George A Breon & Company Inc Preparation of desoxycholic acid
US2615902A (en) * 1950-10-24 1952-10-28 Merck & Co Inc Chemical compounds and processes for preparing the same
US4113882A (en) * 1974-10-21 1978-09-12 Yamanouchi Pharmaceutical Co., Ltd. Stabilized oral prostaglandin formulation and the process for the preparation thereof
US4866044A (en) * 1985-07-09 1989-09-12 Takeda Chemical Industries, Ltd. Solubilized composition of poorly-soluble pharmaceutical product
ES2033516T3 (es) * 1988-04-08 1993-03-16 Roussel-Uclaf Procedimiento para preparar 9 alfa-hidroxi-17 metileno-esteroides.
FR2754709B1 (fr) * 1996-10-23 1999-03-05 Sanofi Sa Composition cosmetique contenant un antagoniste des recepteurs du neuropeptide gamma et alpha 2 antagonistes susceptibles d'etre incorpores dans une telle composition
GB9910934D0 (en) * 1999-05-11 1999-07-14 Res Inst Medicine Chem Chemical compounds
MXPA06013437A (es) 2004-05-19 2007-03-23 Los Angeles Biomed Res Inst Uso de un detergente para la eliminacion no quirurgica de grasa.
US20060127468A1 (en) 2004-05-19 2006-06-15 Kolodney Michael S Methods and related compositions for reduction of fat and skin tightening
US7754230B2 (en) * 2004-05-19 2010-07-13 The Regents Of The University Of California Methods and related compositions for reduction of fat
US20090317376A1 (en) 2005-06-06 2009-12-24 Georgetown University Medical School Compositions And Methods For Lipo Modeling
KR101916024B1 (ko) * 2007-06-19 2018-11-08 키쎄라 바이오파마슈티컬즈 인코포레이티드 합성 담즙산 조성물, 방법 및 제조물

Also Published As

Publication number Publication date
CR11174A (es) 2010-03-23
PH12013500364A1 (en) 2014-04-28
TWI503327B (zh) 2015-10-11
MX360094B (es) 2018-10-19
CN106083969B (zh) 2018-02-27
EP3002290A3 (en) 2016-06-29
CN106083969A (zh) 2016-11-09
CN108191940A (zh) 2018-06-22
TW200918550A (en) 2009-05-01
CA2690841C (en) 2012-11-27
EP2069383A2 (en) 2009-06-17
EP2407475A2 (en) 2012-01-18
CY1116700T1 (el) 2017-03-15
MY160040A (en) 2017-02-15
EA201000032A1 (ru) 2010-04-30
CN106146594A (zh) 2016-11-23
CR20170070A (es) 2017-04-27
AU2008265721A1 (en) 2008-12-24
CA2789109C (en) 2015-10-06
CA2789109A1 (en) 2008-12-24
EP3002290A2 (en) 2016-04-06
MX2009013664A (es) 2010-04-07
KR101598402B1 (ko) 2016-03-03
HK1223372A1 (en) 2017-07-28
SMAP201000003A (it) 2010-03-01
PT2407475E (pt) 2015-11-20
TW201534684A (zh) 2015-09-16
SI2407475T1 (sl) 2016-03-31
BRPI0813140A2 (pt) 2014-12-23
ES2550504T3 (es) 2015-11-10
HRP20150879T1 (hr) 2015-09-25
EP3002290B1 (en) 2020-09-09
EP2407475B1 (en) 2015-08-12
IL202203A0 (en) 2010-06-16
KR20180061401A (ko) 2018-06-07
KR101863131B1 (ko) 2018-06-01
JP5589102B2 (ja) 2014-09-10
AU2008265721B2 (en) 2014-03-20
BRPI0813140C1 (pt) 2021-05-25
CA2690841A1 (en) 2008-12-24
KR101916024B1 (ko) 2018-11-08
ES2826429T3 (es) 2021-05-18
JP2013075918A (ja) 2013-04-25
KR20160150646A (ko) 2016-12-30
TWI503396B (zh) 2015-10-11
WO2008157635A2 (en) 2008-12-24
NZ581081A (en) 2012-12-21
KR20100031512A (ko) 2010-03-22
KR102061001B1 (ko) 2020-01-03
EP2407475A3 (en) 2012-06-13
PL2407475T3 (pl) 2015-12-31
HK1165807A1 (en) 2012-10-12
EA020806B1 (ru) 2015-01-30
KR20130133881A (ko) 2013-12-09
CN108191940B (zh) 2021-02-09
IL202203B (en) 2018-04-30
SMP201000003B (it) 2010-11-12
KR20150013305A (ko) 2015-02-04
AR067440A1 (es) 2009-10-14
BRPI0813140B1 (pt) 2019-02-05
KR20160025044A (ko) 2016-03-07
JP2010530876A (ja) 2010-09-16
HUE025909T2 (en) 2016-04-28
DK2407475T3 (en) 2015-10-26
ZA200907928B (en) 2011-05-28
CN101711254A (zh) 2010-05-19
WO2008157635A3 (en) 2009-06-04
KR20180122483A (ko) 2018-11-12

Similar Documents

Publication Publication Date Title
JO3172B1 (ar) تركيبة وطريقة وتحضير الصفراء الصناعية
BRPI0608604B8 (pt) moduladores de 2,3-dioxigenase de indolamina e composição farmacêutica
JOP20180077A1 (ar) تركيبات وطرق لحمض صفراوي تخليقي
EA201500530A1 (ru) 1,2,5-оксадиазолы в качестве ингибиторов индоламин-2,3-диоксигеназы
SG10201405377XA (en) Compositions and methods for antibodies targeting complement protein c5
EA201000642A1 (ru) 2'-фтор-2'-дезокситетрагидроуридины в качестве ингибиторов цитидиндеаминазы
MY148253A (en) Azaadamantane derivatives and methods of use
MX377553B (es) Composicion farmaceutica estable y metodos de uso de la misma.
EA201171151A1 (ru) Кристаллические трипептидные ингибиторы эпоксикетон-протеазы
EA201071320A1 (ru) Активаторы глюкокиназы
UA105914C2 (uk) Синтез стирилпіридину, міченого радіоізотопом 18f, з тозилатного прекурсора та стабільна фармацевтична композиція на його основі
MX390779B (es) Composición farmacéutica.
EA200971140A1 (ru) Триарильные соединения и композиции, их содержащие
EA201500650A1 (ru) Фенилацетат l-орнитина и способы его получения
HN2006011218A (es) Composiciones de tigeciclina y métodos de preparación
MX2011014019A (es) Derivados de diazahomoadamantano y sus metodos de uso.
CY1115673T1 (el) Φαρμακευτικες συνθεσεις οι οποιες περιλαμβανουν 2-οξο-1-πυρρολιδινο παραγωγα
CO6290655A2 (es) Inhibidors heterociclicos de estearoil-coa-desaturasa
BR112013003216A2 (pt) composições sintéticas de ácido biliar e métodos
EA201000814A1 (ru) 5-[(3,3,3-трифтор-2-гидрокси-1-арилпропил)амино]-1h-хинолин-2-оны, способ их получения и их применение в качестве противовоспалительных средств
MX2009010174A (es) Derivados de aza-adamantano ester y carbamato y metodos de uso de los mismos.
UA96994C2 (ru) Производные 7-алкинил-1,8-нафтиридонов, способ их получения и их применения в терапии
BR112014011595A2 (pt) método de cimentação e composição de cimento
DOP2009000262A (es) Una composicion de liberacion prolongada que comprende un derivado de somatostatina en microparticulas
ATE552832T1 (de) Antidepressivum-propharmaka